Historical shareholding details of Foreign Portfolio Investors holdings in Glenmark Pharmaceuticals Ltd. (GLENMARK)

Quarterly changes of Foreign Portfolio Investors shareholding in Glenmark Pharmaceuticals Ltd. over the previous quarters

Quarter Name Total no. shares held No. of Holders Percent Holding Pledged Locked
shares % shares %
Dec 2024 Foreign Portfolio Investors Category Ii 3,545,509 27 1.26% 0 0.00% 0 0.00%
Dec 2024 Foreign Portfolio Investors Category I 62,791,227 321 22.25% 0 0.00% 0 0.00%
Sep 2024 Foreign Portfolio Investors Category Ii 4,242,579 30 1.50% 0 0.00% 0 0.00%
Sep 2024 Foreign Portfolio Investors Category I 60,802,437 311 21.55% 0 0.00% 0 0.00%
Jun 2024 Foreign Portfolio Investors Category Ii 5,741,747 22 2.03% 0 0.00% 0 0.00%
Jun 2024 Foreign Portfolio Investors Category I 53,474,062 203 18.95% 0 0.00% 0 0.00%
Mar 2024 Foreign Portfolio Investors Category Ii 5,416,289 18 1.92% 0 0.00% 0 0.00%
Mar 2024 Foreign Portfolio Investors Category I 54,913,043 203 19.46% 0 0.00% 0 0.00%
Dec 2023 Foreign Portfolio Investors Category Ii 5,889,703 19 2.09% 0 0.00% 0 0.00%
Dec 2023 Foreign Portfolio Investors Category I 61,005,652 219 21.62% 0 0.00% 0 0.00%
Sep 2023 Foreign Portfolio Investors Category Ii 6,470,518 20 2.29% 0 0.00% 0 0.00%
Sep 2023 Foreign Portfolio Investors Category I 63,499,109 227 22.50% 0 0.00% 0 0.00%
Jun 2023 Foreign Portfolio Investors Category Ii 9,210,001 20 3.26% 0 0.00% 0 0.00%
Jun 2023 Foreign Portfolio Investors Category I 62,794,592 219 22.25% 0 0.00% 0 0.00%
Mar 2023 Foreign Portfolio Investors Category Ii 10,855,098 18 3.85% 0 0.00% 0 0.00%
Mar 2023 Foreign Portfolio Investors Category I 52,526,529 222 18.62% 0 0.00% 0 0.00%
Dec 2022 Foreign Portfolio Investors Category Ii 7,877,304 17 2.79% 0 0.00% 0 0.00%
Dec 2022 Foreign Portfolio Investors Category I 57,572,419 218 20.40% 0 0.00% 0 0.00%
Sep 2022 Foreign Portfolio Investors Category I 65,280,973 233 23.14% 0 0.00% 0 0.00%
Jun 2022 Total 68,362,394 221 24.23% 0 0.00% 0 0.00%
Mar 2022 Total 68,047,528 219 24.12% 0 0.00% 0 0.00%
Dec 2021 Total 68,216,412 220 24.18% 0 0.00% 0 0.00%
Sep 2021 Total 73,168,743 246 25.93% 0 0.00% 0 0.00%
Jun 2021 Total 75,664,847 251 26.82% 0 0.00% 0 0.00%
Mar 2021 Total 72,920,000 254 25.84% 0 0.00% 0 0.00%
Dec 2020 Total 74,723,124 261 26.48% 0 0.00% 0 0.00%
Sep 2020 Total 72,769,764 272 25.79% 0 0.00% 0 0.00%
Jun 2020 Total 66,028,253 275 23.40% 0 0.00% 0 0.00%
Mar 2020 Total 80,451,509 253 28.51% 0 0.00% 0 0.00%
Dec 2019 Total 85,103,327 287 30.16% 0 0.00% 0 0.00%
Sep 2019 Total 88,518,504 466 31.37% 0 0.00% 0 0.00%
Jun 2019 Total 87,587,133 497 31.04% 0 0.00% 0 0.00%
Mar 2019 Total 92,034,745 499 32.62% 0 0.00% 0 0.00%
Dec 2018 Total 91,064,181 498 32.27% 0 0.00% 0 0.00%
Sep 2018 Total 87,189,498 433 30.90% 0 0.00% 0 0.00%
Jun 2018 Total 86,364,955 429 30.61% 0 0.00% 0 0.00%
Mar 2018 Total 86,753,059 434 30.75% 0 0.00% 0 0.00%
Dec 2017 Total 87,543,416 441 31.03% 0 0.00% 0 0.00%
Sep 2017 Total 93,799,516 456 33.24% 0 0.00% 0 0.00%
Jun 2017 Total 94,558,115 449 33.51% 0 0.00% 0 0.00%
Mar 2017 Total 98,086,968 498 34.76% 0 0.00% 0 0.00%
Dec 2016 Total 97,010,102 467 34.38% - -% - -%
Sep 2016 Total 100,557,629 483 35.64% - -% - -%
Jun 2016 Total 103,431,492 499 36.66% - -% - -%
Mar 2016 Total 102,598,088 499 36.36% - -% 10,800,000 -%
Dec 2015 Total 104,015,293 506 36.86% - -% 10,800,000 -%

View all shareholdings details of Glenmark Pharmaceuticals Ltd.